Precision Biologic Inc.

Dartmouth, NS

UEI
ZHG5MJCMU9N6
CAGE
L4996
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
International Organization
Corporate family
SAM.gov registration date
Physical address
140 Eileen Stubbs Ave, Dartmouth, NS B3B 0A9, Canada
Founded
1983
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract vehicles

No active vehicles.

1 expired vehicle

Contract awards

Award Agency Obligated Awarded
Lab reagents 75D30121F11926 CDC Pittsburgh $16,142
Precision biologic reagents 75D30120P09155 CDC Pittsburgh $15,540
Laboratory supplies VA25612P0155 Veterans Integrated Service Network 19 (VHA) $6,536
Lab supplies VA673A10681 Veterans Integrated Service Network 8 (VHA) $18,281
Medical, dental & veterinary EQ V580P10608 Veterans Integrated Service Network 17 (VHA) $7,170

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Precision Biologic Inc. is a manufacturer of innovative products for the clinical laboratory assessment of blood coagulation disorders, with a focus on hemostasis. The company develops and markets CRYOcheck, a line of specialty reagents and controls used to diagnose blood clotting disorders and monitor anticoagulant therapy.

Precision Biologic Inc. has been awarded prime federal contracts by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to provide laboratory reagents and diagnostic products. In 2021, the CDC awarded a $16,142 delivery order against the GSA Schedule for in vitro diagnostics, reagents, and test kits for laboratory reagents. Additionally, in 2020, the CDC issued a $15,540 purchase order to Precision Biologic for the company's reagents. These contracts were awarded under the FSS 65-VII Schedule for In Vitro Diagnostics, Reagents, Test Kits, and Test Sets, with no set-aside designations.

Precision Biologic Inc. currently holds a Federal Supply Schedule contract under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, Test Kits, and Test Sets. Awarded by the Department of Veterans Affairs Veterans Health Administration (VHA) Veterans Integrated Service Network 12, this multiple award, indefinite-delivery vehicle has a potential value of $800,000 over the five-year period from March 1, 2023 through February 29, 2028. With no set-aside specified, this contract allows the VHA to procure Precision Biologic's line of laboratory diagnostic reagents, test kits, and related supplies to support the healthcare needs of veterans nationwide through task order awards issued against the IDV.

Quick answers

Is Precision Biologic Inc. registered in SAM.gov?

Yes. Precision Biologic Inc.'s SAM.gov registration is active through June 2, 2027.

What is Precision Biologic Inc.'s CAGE code?

Precision Biologic Inc.'s CAGE code is L4996, and its Unique Entity ID (UEI) is ZHG5MJCMU9N6.

Which contract vehicles does Precision Biologic Inc. hold?

Precision Biologic Inc. holds a place on 1 federal contract vehicle: FSS-65-VII.

What is Precision Biologic Inc.'s most recent federal award?

Precision Biologic Inc.'s most recent federal contract award is Lab reagents (75D30121F11926), from CDC Pittsburgh, on July 20, 2021.

On GovTribe

See Precision Biologic Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe